<DOC>
	<DOCNO>NCT01432002</DOCNO>
	<brief_summary>The purpose study : - ass potential benefit 18F- [ FDG ] PET/CT PET/MRI operable breast cancer order define size location primary tumor , well axillary , supraclavicular internal mammary lymph node . - apply image result simulation radiation treatment plan partial breast 3-D radiation treatment partial breast irradiation intensity modulate radiation treatment ( IMRT ) .</brief_summary>
	<brief_title>FDG-PET/CT Simulation Radiation Treatment Planning Early Breast Cancer</brief_title>
	<detailed_description>Pre-operative FDG PET/CT , option PET/IRM , intend woman histologically confirm operable clinically node-negative breast cancer , breast conserve post-operative radiotherapy plan .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histologically confirm breast carcinoma Clinical stage T12 N0 M0 Age &gt; 18 year Signed informed consent WHO performance index 3 Premenopausal woman without contraception Gestation Lactating Prior surgery radiotherapy breast Unable understand study participation Bilateral breast cancer Prior CT thoraxabdomen breast MRI within 4 month interview Presence electromechanical implant and/or body ferromagnetic material Previous history renal insufficiency require dialysis and/or hospitalisation Ureum and/or creatinine within 2 week interview lab 's reference limit History contrast allergy Hyperthyroidy Claustrophobia .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>breast carcinoma</keyword>
	<keyword>FDG</keyword>
	<keyword>PET/CT</keyword>
	<keyword>PET/IRM</keyword>
</DOC>